Targeted Metabolite Identification and Quantification
The Biocrates AbsoluteIDQ® Kits deliver the widest available range of metabolomic information in a single assay more
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
AbsoluteIDQ® Stero17 Kit
UHPLC column
HPLC column
Austrian BIOCRATES Life Sciences AG, cutting-edge developer of metabolomic kits, has launched its new steroid hormone screening assay, the AbsoluteIDQ® Stero17 Kit, allowing a simultaneous analysis of a panel of 17 steroid hormones using tandem mass spectrometry - from a single blood sample.
What is AbsoluteIDQ® Stero17? The AbsoluteIDQ® Stero17 Kit covers the standardized quantitative analysis of 17 steroid hormones from only a single blood sample using (U)HPLC-MS/MS, a technology meeting the most stringent quality control criteria for routine diagnostics, ensuring a high level of analytical sensitivity and selectivity, and guaranteeing superior accuracy and excellent precision for robust results. The kit, which has been approved by proficiency tests, comes complete with isotope-labeled internal standards, reagents, and protocols for sample preparation based on solid-phase extraction in a 96-well plate format and subsequent (U)HPLC-ESI-MS/MS analysis in highly specific multiple reaction monitoring (MRM) mode and a tightly quality-controlled workflow.
KEY Benefits
Steroid hormones - central to many of life’s processes. Steroid hormones play a crucial role in a wide range of physiological processes. Glucocorticoids are not only involved in carbohydrate metabolism, they also affect the lipid and protein metabolism and play an important role in the reaction to stress. Estrogens and progestagens regulate almost all of the reproductive processes in women. Inborn or acquired disorders of steroid hormone metabolism have been the source of a number of serious diseases (e.g. Cushing syndrome, adrenal tumors, hyperaldosteronism).
This shows how significant the role of steroid hormones in the body may play and how important the quantitative analysis of steroid hormones in clinical diagnostics and research based applications can be. Particularly the main advantages of LC-MS/MS compared to immunoassays are multiplexing (simultaneous analysis of multiple target analytes), higher specificity (by so-called multiple reaction monitoring (MRM), greater dynamic range of the calibration and lower inter-laboratory variability (including diversity in sample preparation, calibrators and analytical methods).
For further information please visit our product website, download our product brochure or get in contact with us!
Contact / Request information
Contact the supplier and request further information free of charge:
Watchlist
This is where you can add this product to your personal favourites
Additional Information
Targeted Metabolite Identification and Quantification
The Biocrates AbsoluteIDQ® Kits deliver the widest available range of metabolomic information in a single assay more
Simultaneous Analysis of 17 Steroid Hormones using (U)HPLC-MS/MS
The AbsoluteIDQ® Stero17 Kit covers the standardized quantitative analysis of 17 steroid hormones from a single blood sample using (U)HPLC-MS/MS. more
Metabolomic biomarker research for the early detection of diabetes
Metabolomic biomarker research is a young research area that carries great hopes for both medicine and the nutritional sciences, particularly for the early detection of genetically determined diseases. The first Round Table Meeting on Metabolomics & Diabetes took place in Vienna, bringing ... more
BIOCRATES expands management board: New Chief Technology Officer (CTO) Dr. Ralph Zahn
BIOCRATES Life Sciences AG has employed Dr. Ralph Zahn as new CTO (Chief Technology Officer), since October 2010. „The constant development of our products and the affiliated technical and scientific assignments made a CTO necessary. Dr. Zahn and his expertise are a valuable enrichment to o ... more
BIOCRATES Life Sciences AG and Selexis SA have entered into a co-development agreement to further increase drug substance yields from mammalian cell cultures. Because most protein therapeutics require specific post-translational modifications (e.g., glycosylation) to exert their full therap ... more